Literature DB >> 17322580

The effects of experimental hyperthyroidism on hemorheology and plasma fibrinogen concentration.

S Ozdemir1, R Yücel, N Dariyerli, S Toplan, M C Akyolcu, G Yigit, H Hatemi.   

Abstract

The present study in female rats determined the effects of experimental hyperthyroidsm on hemorheological parameters and fibrinogen concentration. To induce experimental hyperthyroidism L-thyroxine (0.4 mg/100 g fodder) was added to the fodder of the experimental group rats for 20 d. After experimental duration, T3, T4, and TSH levels, plasma and blood viscosity, hematocrit, erythrocyte rigidity index, and plasma fibrinogen concentration values of both the control and the experimental group animals were determined and evaluated. In the experimental group, T3 and T4 levels were higher and TSH levels lower than that of the control rats (respectively, p < 0.01, p < 0.001, p < 0.001). Plasma viscosity and fibrinogen concentration of hyperthyroid group were found significantly higher than controls (p < 0.01). However there was no significant difference found in blood viscosity, hematocrit, and erythrocyte rigidity index between control and experimental groups. Thus, hyperthyroidism induced increased fibrinogen concentration can alter the rheological structure of blood by inducing increase in plasma viscosity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17322580     DOI: 10.1385/ENDO:30:2:203

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  16 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

Review 3.  Rheological influences on thrombosis.

Authors:  G D Lowe
Journal:  Baillieres Best Pract Res Clin Haematol       Date:  1999-09

4.  Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment.

Authors:  F Marongiu; M Conti; G Mameli; M L Murtas; S Balzano; G Sorano; A M Mamusa; E Martino
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

5.  Blood coagulation and fibrinolysis in patients with hyperthyroidism.

Authors:  C Erem; H O Ersoz; S S Karti; K Ukinç; A Hacihasanoglu; O Değer; M Telatar
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

6.  Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis.

Authors:  K Hymes; M Blum; H Lackner; S Karpatkin
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

Review 7.  Effects of subclinical thyroid dysfunction on the heart.

Authors:  Bernadette Biondi; Emiliano A Palmieri; Gaetano Lombardi; Serafino Fazio
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

8.  The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration.

Authors:  Selmin Toplan; Nuran Dariyerli; Semra Ozdemir; Mehmet Can Akyolcu; Hüsrev Hatemi; Günnur Yigit
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

9.  Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol.

Authors:  J Burggraaf; S Lalezari; J J Emeis; U M Vischer; P H de Meyer; H Pijl; A F Cohen
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

10.  The effects of experimental hypo- and hyperthyroidism on blood viscosity and other blood parameters in the rat.

Authors:  A Kössler; K Hagmüller; R Winkler
Journal:  Biorheology       Date:  1987       Impact factor: 1.875

View more
  1 in total

1.  Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism.

Authors:  Rıfat Yücel; Semra Ozdemir; Nuran Darıyerli; Selmin Toplan; M Can Akyolcu; Günnur Yiğit
Journal:  Endocrine       Date:  2009-10-23       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.